Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Spectranetics Corp.

Jul 2010
Colorado Springs, Colo.-based Spectranetics Corp., a single-use medical device manufacturer, has announced its clinical trial plans related to the treatment of in-stent restenosis in arteries above the knee. Currently, there are no devices cleared or approved by the FDA to treat in-stent restenosis. The company has planned to initiate a multicenter randomized trial in the US to compare laser ablation followed by adjunctive balloon angioplasty with balloon angioplasty alone.

laser ablation
The removal of material from a surface by high intensity pulsed or CW laser radiation emission.
adjunctive balloon angioplastyAmericasangioplastyBiophotonicsBusinessclinical trialFDAin-stent restenosiskneelaser ablationmedicalRapidScanrestenosisSpectranetics Corp.USlasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!